Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice

Hum Mol Genet. 2006 Dec 1;15(23):3429-35. doi: 10.1093/hmg/ddl419. Epub 2006 Oct 24.

Abstract

Min mice provide a good model of human familial adenomatous polyposis. Recently, we have reported on two recombinant inbred lines (I and V) and the location of a modifier (Mom3) close to Apc, which altered polyp numbers in our mice possibly by modifying the frequency of wild-type (WT) allele loss at Apc; mice with severe disease (line V) showed elevated rates of loss. We now show that in line I only, a single pregnancy caused a significant increase in adenoma multiplicity compared with virgin controls (P<0.001) and that an additional pregnancy conferred a similar risk. Pregnancy was linked to both adenoma initiation and enhanced tumour growth in line I mice, and interline crosses indicated that susceptibility to pregnancy-associated adenomas was under genetic control. We found no evidence for the involvement of oestrodial metabolizing genes or the oestrogen receptors (Esr1 and 2) in tumour multiplicity. Importantly, a significantly elevated frequency of WT allele loss at Apc was observed in adenomas from parous mice (line and backcrossed) carrying the line I Min allele relative to equivalent virgin controls (P=0.015). Our results provide the first experimental evidence for genetic determinants controlling pregnancy-associated tumourigenesis; analogous genetic factors may exist in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenomatous Polyposis Coli / genetics*
  • Animals
  • Chromosome Mapping
  • Disease Models, Animal
  • Female
  • Gene Frequency
  • Genes, APC*
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease*
  • Humans
  • Mice
  • Mice, Mutant Strains
  • Pregnancy
  • Pregnancy Complications, Neoplastic / genetics*
  • Receptors, Estrogen / genetics

Substances

  • Genetic Markers
  • Receptors, Estrogen